EFG Asset Management North America Corp. cut its holdings in shares of Hawkins, Inc. (NASDAQ:HWKN – Free Report) by 13.6% during the third quarter, Holdings Channel.com reports. The fund owned 21,017 shares of the specialty chemicals company’s stock after selling 3,296 shares during the period. EFG Asset Management North America Corp.’s holdings in Hawkins were worth $3,843,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently made changes to their positions in HWKN. AQR Capital Management LLC grew its position in shares of Hawkins by 9.0% during the first quarter. AQR Capital Management LLC now owns 12,331 shares of the specialty chemicals company’s stock worth $1,306,000 after purchasing an additional 1,017 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Hawkins by 4.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,499 shares of the specialty chemicals company’s stock valued at $1,218,000 after buying an additional 494 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in Hawkins by 9.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 52,778 shares of the specialty chemicals company’s stock valued at $5,590,000 after buying an additional 4,400 shares in the last quarter. Jane Street Group LLC raised its position in shares of Hawkins by 83.2% during the first quarter. Jane Street Group LLC now owns 38,416 shares of the specialty chemicals company’s stock valued at $4,069,000 after buying an additional 17,447 shares during the last quarter. Finally, GAMMA Investing LLC lifted its holdings in shares of Hawkins by 24.1% in the second quarter. GAMMA Investing LLC now owns 659 shares of the specialty chemicals company’s stock worth $94,000 after buying an additional 128 shares in the last quarter. Institutional investors own 69.71% of the company’s stock.
Wall Street Analyst Weigh In
HWKN has been the subject of several research analyst reports. Zacks Research raised shares of Hawkins from a “strong sell” rating to a “hold” rating in a research note on Friday, January 2nd. Weiss Ratings downgraded shares of Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, January 12th. Finally, BWS Financial reaffirmed a “buy” rating and issued a $200.00 target price on shares of Hawkins in a report on Monday, November 3rd. Two analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $162.50.
Hawkins Price Performance
HWKN stock opened at $153.23 on Tuesday. Hawkins, Inc. has a 52 week low of $98.30 and a 52 week high of $186.15. The firm has a market capitalization of $3.20 billion, a P/E ratio of 38.50, a price-to-earnings-growth ratio of 2.39 and a beta of 0.86. The company has a fifty day simple moving average of $143.02 and a two-hundred day simple moving average of $156.60. The company has a quick ratio of 1.49, a current ratio of 2.43 and a debt-to-equity ratio of 0.53.
Hawkins (NASDAQ:HWKN – Get Free Report) last posted its earnings results on Wednesday, October 29th. The specialty chemicals company reported $1.08 earnings per share for the quarter, missing analysts’ consensus estimates of $1.24 by ($0.16). The business had revenue of $280.43 million during the quarter, compared to the consensus estimate of $284.42 million. Hawkins had a return on equity of 17.42% and a net margin of 7.95%. Analysts anticipate that Hawkins, Inc. will post 4 earnings per share for the current fiscal year.
Insiders Place Their Bets
In related news, VP Drew M. Grahek acquired 1,587 shares of Hawkins stock in a transaction on Monday, November 3rd. The shares were bought at an average cost of $126.34 per share, with a total value of $200,501.58. Following the completion of the purchase, the vice president directly owned 39,640 shares of the company’s stock, valued at $5,008,117.60. The trade was a 4.17% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. 4.10% of the stock is owned by insiders.
About Hawkins
Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.
Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.
Featured Stories
- Five stocks we like better than Hawkins
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- Executive Order 14330: Trump’s Biggest Yet
Want to see what other hedge funds are holding HWKN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hawkins, Inc. (NASDAQ:HWKN – Free Report).
Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.
